/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / TORONTO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Montauk Metals Inc. (TSX-V: MTK) (the “Company” or “Montauk”) filed a corporate assignment into bankruptcy pursuant to the Bankruptcy and Insolvency Act (Canada) (the “BIA”). The filing comes after the Board was unable to reach a settlement with its creditors. The Fuller Landau Group Inc. has been appointed as the Licensed Insolvency Trustee (the “Trustee”) under th ...

Core Insights - AlphaTON Capital has not engaged in equity line financing with ATW Partners and maintains a low debt to equity ratio of 7% [1][11] - The company has transformed its balance sheet into a diversified portfolio of digital assets since its PIPE funding on September 25, 2025, focusing on the Telegram ecosystem [2][3] - AlphaTON Capital aims to create a closed-loop ecosystem that integrates various digital assets and applications, enhancing value across its operations [4][11] Strategic Initiatives - The company has launched the "AlphaTON World Tour" to educate institutional investors about the intersection of social media and decentralized finance [7] - AlphaTON is transitioning to an active operator model, incubating and acquiring cash-flowing businesses within the Telegram Mini-App economy [7] - The company is leveraging its legacy biotech assets while exploring innovations at the intersection of healthcare and blockchain technology [11] Financial Overview - AlphaTON has completed an acquisition of approximately $30 million in digital assets, with a current total asset value of $28.6 million [8] - The company has deployed 4 million TON into institutional staking contracts, generating predictable network rewards [11] - AlphaTON's treasury is currently trading at a 0.70 mNAV, indicating it is undervalued [8] Strategic Partnerships and Acquisitions - AlphaTON has executed a binding LOI with Animoca Brands to acquire a 51% equity interest in GAMEE, a mobile gaming platform [11] - The company has entered a joint venture with PagoPay and ALT5 Sigma to launch a co-branded TON Mastercard for crypto-to-fiat spending [11] - AlphaTON is collaborating with SingularityNET and others to develop decentralized AI infrastructure within the Telegram ecosystem [11] Leadership and Governance - The company has strengthened its leadership team with key appointments, including a new CFO, CPO, CTO, and CMO, to support its growth strategy [13][16] - The leadership team brings extensive experience in blockchain economics, commercial strategy, technical infrastructure, and digital asset communications [16]

Core Insights - ECD Automotive Design, Inc. reported its third quarter financial results for 2025, highlighting a focus on operational improvements and cost containment while expanding its product lineup with new collaborations and builds [1][5][10]. Financial Performance - Revenue for the third quarter of 2025 was $5.8 million, a decrease from $6.4 million in the same quarter of 2024 [10][11]. - The company experienced a gross loss of $1.7 million in Q3 2025, compared to a gross profit of $2.0 million in Q3 2024, primarily due to the completion of legacy builds and increased tariff-related costs [10][11]. - Net income for the third quarter was $2.2 million, a significant improvement from a net loss of $2.6 million in the prior year, attributed to a non-cash gain from the conversion of debt into preferred stock [10][13]. - Operating expenses increased to $3.4 million, up by $0.8 million from the previous year, mainly due to higher legal fees and lease recognition [12]. - The operating loss for the quarter was reported at $5.0 million, an increase of $4.4 million from the prior year, driven by reduced gross margins and higher administrative costs [12]. Strategic Developments - The company is implementing cost-containment measures expected to yield over $1 million in annual savings through headcount and overhead reductions while maintaining craftsmanship and production capabilities [6][8]. - ECD has diversified its product offerings, including a collaboration with Chelsea Truck Company to produce modern Land Rover Defenders and INEOS Grenadiers, which is anticipated to enhance manufacturing resource utilization [7][10]. - The completion of the first bespoke Porsche 911 build marks ECD's entry into the Porsche restoration market, receiving recognition at a car show [7][10]. Future Outlook - Management believes that the operational groundwork established in Q3 2025 will lead to improved financial performance and sustained value creation as the company progresses into 2026 [8].

Core Insights - Mesoblast Limited is collaborating with the NIH-funded Blood and Marrow Transplant Clinical Trials Network to conduct a pivotal trial of Ryoncil for adults with severe steroid-refractory acute graft versus host disease (SR-aGvHD) [1][2][3] - The trial aims to address the high mortality rates in patients who do not respond to corticosteroids, with survival rates as low as 20-30% by Day 100 after failing ruxolitinib [2] - Ryoncil has shown promising results in pediatric patients, with a 76% survival rate at Day 100 in adults who failed other treatments [2][5] Company Overview - Mesoblast is a leader in developing allogeneic cellular medicines for severe inflammatory diseases, utilizing a proprietary mesenchymal lineage cell therapy technology platform [4][6] - The company has a strong intellectual property portfolio with over 1,000 patents or applications, providing commercial protection until at least 2044 [7] - Mesoblast is expanding its product offerings, with Ryoncil being developed for additional indications beyond SR-aGvHD, including biologic-resistant inflammatory bowel disease and heart failure [6] Clinical Development - The pivotal trial for Ryoncil will randomize patients as early as possible after corticosteroid refractoriness, comparing ruxolitinib alone versus ruxolitinib combined with Ryoncil [3] - The trial protocol is set to be submitted to the FDA to initiate enrollment in the first quarter of 2026 [3] - The collaboration with BMT CTN is significant as it represents U.S. centers performing approximately 80% of all U.S. allogeneic bone marrow transplants [1][10]

This represents an important step in advancing the “FFAI + AIXC” dual-flywheel, dual-bridge, and dual-listed company framework and supports the ongoing development of EAI + Crypto initiatives aimed at bridging Web2 and Web3.FFAI will continue advancing its EAI ecosystem while progressing toward key product milestones, including the first FX Super One pre-production vehicle coming off the U.S. line by year-end and the first delivery in the UAE on November 27.AIxC could benefit FFAI across five key areas: fin ...

MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended September 30, 2025. Key highlights include: (CAD)Q3 2025% Change vs.Q3 2024YTD 2025% Change vs.YTD 2024Trailing Twelve Months (TTM) Sept 30, 2025% Change vs.TTM Sept 30, 2024Canadian Pharma Sales9,864,254+19%28,351,130+16%<td style="border-right: solid black 1pt ; text-align: right ; vertical-align: middle; vertical-ali ...

Core Points - Namib Minerals will host a webcast and conference call for a business update on November 24, 2025, at 8:00 AM ET [1] - The company operates in the African gold mining sector, with a focus on Zimbabwe and the Democratic Republic of Congo [4] Company Information - Namib Minerals is a gold producer, developer, and explorer, significantly contributing to Africa's mining industry [4] - The company currently operates the How Mine, an underground gold mine in Zimbabwe, and plans to restart two additional assets in Zimbabwe [4] - Namib Minerals also has exploration assets in the Democratic Republic of Congo [4] Investor Engagement - Interested parties can access the live conference call via the company's Investor Relations website, and an archived replay will be available after the event [2] - Shareholders can submit questions for the management during the webcast by emailing the investor relations team [3]

Core Points - BioSyent Inc. has declared a quarterly dividend of $0.05 per common share, payable on December 15, 2025, to shareholders of record on November 28, 2025 [1] - The dividend for the fourth quarter of 2025 is consistent with the third quarter of 2025, indicating stable dividend policy [1] - The dividend qualifies as an 'eligible dividend' for Canadian income tax purposes [1] Company Overview - BioSyent Inc. is a profitable growth-oriented specialty pharmaceutical company listed on the TSX Venture Exchange under the symbol "RX" [2] - The company focuses on in-licensing or acquiring innovative pharmaceutical and healthcare products that are safe, effective, and have a proven track record [2] - BioSyent markets its products through community, specialty, and international business units to support healthcare professionals [2] Share Information - As of the date of the press release, BioSyent has 11,262,282 common shares outstanding [3]

Core Insights - Domo has partnered with Formula 1 driver Alex Albon to demonstrate the impact of data on performance in racing and business [2][4][6] - The collaboration will run through the 2026 season and includes various initiatives aimed at enhancing fan engagement and showcasing data-driven decision-making [2][4][5] Company Overview - Domo is an AI and Data Products platform that enables businesses to leverage data and AI for value creation [7] - The platform supports users in preparing, visualizing, automating, and distributing data products, enhancing the overall data journey [7] Partnership Details - The partnership will feature exclusive content, interactive experiences, and VIP hospitality opportunities at select Formula 1 races [5][6] - Domo and Albon aim to highlight the intersection of human instinct and data-driven intelligence in achieving measurable results [3][4] Industry Context - The collaboration emphasizes the importance of data in modern racing, where every decision is informed by billions of data points, paralleling the best practices in business [4][6] - The initiative aims to redefine fan engagement in Formula 1 by turning insights into impactful experiences [7]

SCOTTSDALE, Ariz., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Meritage Homes Corporation (NYSE: MTH, “Meritage” or the “Company”), the fifth-largest homebuilder in the U.S., today announced that its Board of Directors has declared a quarterly dividend of $0.43 per share. This dividend is payable on December 31, 2025 to shareholders of record as of the close of trading on December 17, 2025. As of November 20, 2025, Meritage has repurchased $128 million of shares in the fourth quarter and $273 million of shares on a y ...